IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.788
EU - Europa 9.880
AS - Asia 9.268
SA - Sud America 2.802
Continente sconosciuto - Info sul continente non disponibili 627
AF - Africa 538
OC - Oceania 12
AN - Antartide 1
Totale 42.916
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.340
SG - Singapore 2.662
BR - Brasile 2.180
VN - Vietnam 2.113
RU - Federazione Russa 1.689
UA - Ucraina 1.497
IT - Italia 1.458
CN - Cina 1.344
IE - Irlanda 954
HK - Hong Kong 913
DE - Germania 905
SE - Svezia 833
TR - Turchia 764
FI - Finlandia 605
DK - Danimarca 599
FR - Francia 575
GB - Regno Unito 338
KR - Corea 325
IN - India 239
CA - Canada 237
AR - Argentina 229
BD - Bangladesh 228
CI - Costa d'Avorio 180
MA - Marocco 125
MX - Messico 118
NL - Olanda 109
ID - Indonesia 101
EC - Ecuador 91
JP - Giappone 89
ZA - Sudafrica 87
IQ - Iraq 86
CO - Colombia 83
VE - Venezuela 68
PL - Polonia 62
UZ - Uzbekistan 57
ES - Italia 55
EU - Europa 54
CL - Cile 45
PY - Paraguay 45
PK - Pakistan 42
AT - Austria 41
TN - Tunisia 40
PH - Filippine 36
EG - Egitto 29
PE - Perù 28
MY - Malesia 27
SA - Arabia Saudita 27
BE - Belgio 25
DZ - Algeria 25
KZ - Kazakistan 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
CR - Costa Rica 20
UY - Uruguay 19
LT - Lituania 18
CZ - Repubblica Ceca 16
TH - Thailandia 16
IL - Israele 14
JM - Giamaica 13
KE - Kenya 13
OM - Oman 13
RS - Serbia 13
BO - Bolivia 12
NP - Nepal 12
RO - Romania 12
AZ - Azerbaigian 11
AL - Albania 10
TW - Taiwan 10
AU - Australia 9
GT - Guatemala 9
LB - Libano 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GR - Grecia 8
HU - Ungheria 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
SN - Senegal 8
BG - Bulgaria 7
HN - Honduras 7
KW - Kuwait 7
PA - Panama 7
PR - Porto Rico 7
IR - Iran 6
MN - Mongolia 6
AO - Angola 5
SY - Repubblica araba siriana 5
GA - Gabon 4
HR - Croazia 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BZ - Belize 3
EE - Estonia 3
GE - Georgia 3
LU - Lussemburgo 3
LV - Lettonia 3
Totale 42.285
Salva come PNG Salva come JPEG
Città #
Ashburn 3.166
Jacksonville 1.575
Singapore 1.455
Dallas 1.043
Chandler 1.023
Dublin 945
Fairfield 945
Hong Kong 885
Boardman 851
Council Bluffs 818
San Jose 776
Ho Chi Minh City 709
Wilmington 537
Hanoi 473
The Dalles 465
New York 435
Houston 417
Princeton 364
Seattle 364
Woodbridge 364
Lawrence 358
Lauterbourg 345
Des Moines 325
San Mateo 321
Los Angeles 313
Moscow 303
Beijing 281
Milan 264
Cambridge 257
Ann Arbor 252
Helsinki 245
São Paulo 243
Hefei 229
Abidjan 180
Chicago 163
San Diego 139
Munich 126
Da Nang 122
Buffalo 119
Centro 104
Orem 102
Santa Clara 96
Haiphong 90
Phoenix 87
Turin 77
Ancona 73
London 73
Toronto 71
Redmond 70
Miano 68
Shanghai 64
Denver 61
Guangzhou 61
Rio de Janeiro 59
Tokyo 59
Rome 57
Salt Lake City 55
Turku 53
Atlanta 52
Curitiba 51
Chennai 48
Brooklyn 47
Warsaw 47
Amsterdam 46
Montreal 46
Tashkent 45
Johannesburg 43
Nuremberg 43
Hải Dương 42
Pune 42
Belo Horizonte 40
San Francisco 39
Frankfurt am Main 38
Washington 38
Stockholm 37
Biên Hòa 36
Thái Bình 36
Boston 35
Columbus 35
Brasília 34
Philadelphia 32
Venice 32
Guayaquil 31
Elk Grove Village 29
Manchester 29
Wuhan 29
Campinas 28
Izmir 27
Pianella 27
Poplar 27
Porto 27
Milwaukee 26
Baghdad 25
Mumbai 25
Quito 25
Dhaka 24
Marche 24
Medellín 24
Mexico City 24
Thái Nguyên 24
Totale 25.034
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 390
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 340
Specific Anti-Nuclear Antibodies, Clinical Features and Outcome Following Treatment with Nilotinib In Patients with Chronic Graft-Versus-Host Disease. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions 326
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 232
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 218
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 210
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 202
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 196
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 193
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 193
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 192
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 187
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 180
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 180
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 178
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 177
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 175
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 174
Glial-like differentiation potential of human mature adipocytes 174
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 174
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 173
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 172
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 171
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 170
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 167
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 166
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 166
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 164
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 161
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 159
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 159
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 158
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 157
[Hodgkin's lymphoma and secondary leukemias]. 156
Bone marrow adipocytes support haematopoietic stem cell survival 156
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 155
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 155
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 155
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 154
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 153
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 153
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 153
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 153
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 152
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 151
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 150
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 150
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 150
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 149
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 149
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 149
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 149
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 148
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 147
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 146
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 146
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 145
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 145
Plasticity of human dedifferentiated adipocytes toward endothelial cells 143
A rare case of aCML associated with CNS involvement and with aggressive clinical course 143
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 142
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 142
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 141
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 141
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 140
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 140
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 139
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 138
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 137
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 137
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 136
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 136
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 136
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 135
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 135
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 135
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 134
[Beta 2-microglobulin in lymphoproliferative disorders]. 134
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 134
Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 133
Molecular and functional characterization of human bone marrow adipocytes 133
Current Main Topics in Multiple Myeloma 132
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 131
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 131
T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT 131
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 131
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 131
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up 130
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 129
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 129
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 129
A novel homozygous stop-codon mutation in human HFE responsible for nonsense-mediated mRNA decay 128
History and scientific production of clinica medica and clinica ematologica in ancona 128
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 128
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 127
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 127
[Hairy cell leukemia: therapy with lithium carbonate]. 127
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 127
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 126
Hyperchidam Verona897 regimen is effective in treatment of advanced peripheral T cell lymphoma (PTCL): The GITIL experience in 33 cases 126
Totale 15.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 204.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.845 0 0 0 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.592 453 64 136 431 439 402 70 58 16 66 59 398
2024/20255.800 644 525 173 61 170 165 753 170 1.205 450 541 943
2025/202616.123 1.004 1.174 1.413 2.113 1.246 1.044 2.647 1.530 1.251 1.263 596 842
2026/20273.159 637 601 734 1.187 0 0 0 0 0 0 0 0
Totale 42.916